| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |